JavaScriptが無効です。ブラウザの設定でJavaScriptを有効にしてください
再生時間:
投稿日:
動画サイト:
画質:
Cell and Gene Therapy · Cell & Gene Therapies have created a turning point in personalized medicine and how we treat disease. · Meet Cameron: Using CRISPR to ...
YouTube-Novartis
Novartis strategic growth highlights were summarized for investors at 2024 J.P. Morgan Healthcare Conference. Outlining our focused strategy ...
One of the world's leading medicines companies, Novartis is discovering and developing novel, high-value medicines to address society's most ...
At Novartis we create value for our stakeholders by developing new medicines and bringing them to as many people as possible.
Intro
Innovation
Core therapeutic areas
Operations & supply chain
Access for patients
Our mission is to discover new ways to improve and extend people's lives. We use science-based innovation to address some of society's most ...
Novartis's transformation into a pure-play Innovative Medicines company was outlined to investors by our CEO, Vas Narasimhan.
Evolution to pure-play
Vision
Strategy
R&D focus
Summary - top takeaways
25 years of Novartis, more than 250 years on innovation. For a quarter of a century, Novartis has been reimagining medicine by constantly ...
Transforming cancer care
Malaria Initiative
Novartis Today
Comments ; Bridging barriers to healthcare: A blueprint for future global health · 2K views ; Novartis Strategy & Growth Update · 150K views ; The ...
We are passionate about what we do and the impact we have on patients and associates. We are Novartis and we are reimagining medicine.
Novartis CEO, Vas Narasimhan shares the Company's strategy and growth update at the annual J.P. Morgan Healthcare Conference 2024.
Novartis business deals across mergers & acquisitions, business development & licensing were summarized for investors at 2024 J.P. Morgan ...
Novartis's next generation Technology Platforms strategy was outlined to investors by our CEO, Vas Narasimhan. Our new strategy provides a ...
Advanced technology platforms
Gene therapy
Cell therapy
Radioligand therapy
Novartis is transforming into a 'pure-play' Innovative Medicines company. Our focused strategy, core therapeutic areas, technology platforms ...
Novartis is committed to supporting communities, ensuring access to medicines, and contributing to research efforts.
More than 20 years ago today, Novartis signed an agreement with World Health Organization to make its antimalarial available without profit ...
In 2023, we entered our new era as an innovative medicines company, working every day to restore possibilities for the millions of people ...
YouTube-Novartis Careers
Novartis CEO Vas Narasimhan talks about his management approach and the appeal of working in the pharma industry.
Bloomberg.com-Bloomberg
Novartis CEO Vas Narasimhan joins 'Squawk on the Street' to discuss what's driving the company's earnings beats, the company's newest ...
YouTube-CNBC Television
Understanding Clinical Trials. What's a clinical trial, anyway? Read more about Clinical Trials at Novartis: https://bit.ly/3Fl7vKh.
Comments ; Novartis transformation into a pure-play Innovative Medicines company · 482K views ; Drug discovery and development process · 542K views.